These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21453891)

  • 1. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y; Debbeche R; Hamzaoui L; Lounissi M; Trabelsi S; Bouzaidi S; Salem M; Abdelmoula L; Najjar T
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease.
    Iizuka M; Sagara S; Etou T
    Inflamm Bowel Dis; 2011 Jul; 17(7):E67-8. PubMed ID: 21509909
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C; Calado J; Cravo M
    BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn's disease.
    Tada Y; Ishihara S; Ito T; Matsui K; Sonoyama H; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Sato S; Adachi K; Ikeuchi H; Kinoshita Y
    Intern Med; 2013; 52(17):1899-902. PubMed ID: 23994979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unexplained inflammatory syndrome could be due to renal amyloidosis associated to Crohn's disease].
    Fekih M; Hefaiedh R; Matri S; Djebbi S; Boubaker J; Filali A
    Tunis Med; 2008 Nov; 86(11):1022-3. PubMed ID: 19213504
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP; Chapman FA; Bellamy CO; Save V; Plevris JN; Shand AG; Whitworth C; Dhaun N
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infliximab and amyloidosis secondary to inflammatory bowel diseases].
    Callejas Rubio JL; Ortego Centeno N; Cárdeña Pérez C; Navas-Parejo A
    Med Clin (Barc); 2005 May; 124(19):757-8; author reply 758. PubMed ID: 15919041
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal amyloidosis after a short period since diagnosis of ileocolonic Crohn's disease.
    Karaahmet F; Akinci H; Hamamci M; Bahceci M; Coban S; Yuksel I
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):473-4. PubMed ID: 24369336
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare case of pericarditis, complication of infliximab treatment for Crohn's disease.
    Devasahayam J; Pillai U; Lacasse A
    J Crohns Colitis; 2012 Jul; 6(6):730-1. PubMed ID: 22465046
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic vulval Crohn's disease and infliximab: a case report.
    Tritton SM; Whyte L; Fischer G
    J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent Crohn's uveitis with infliximab.
    Ally MR; Veerappan GR; Koff JM
    Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.
    Iizuka M; Konno S; Horie Y; Itou H; Shindo K; Watanabe S
    Gut; 2006 May; 55(5):744-5. PubMed ID: 16609139
    [No Abstract]   [Full Text] [Related]  

  • 15. Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab.
    Chiba M; Sugawara T; Tsuda H; Abe T; Tokairin T; Kashima Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1121-2. PubMed ID: 18942761
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC; Nielsen AM
    Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemorrhagic Crohn's disease controlled with infliximab.
    Meyer MM; Levine EJ
    Inflamm Bowel Dis; 2009 Oct; 15(10):1456-7. PubMed ID: 19107774
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous metastatic Crohn's disease responsive to infliximab.
    Petrolati A; Altavilla N; Cipolla R; Fenderico P; Forlini G; Nasoni S; Rossi Z
    Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory polypoid mass treated with Infliximab in a Crohn's disease patient.
    Liatsos C; Kyriakos N; Panagou E; Karagiannis S; Salemis N; Mavrogiannis C
    J Crohns Colitis; 2010 Dec; 4(6):707-8. PubMed ID: 21122587
    [No Abstract]   [Full Text] [Related]  

  • 20. Colon cancer after infliximab therapy for Crohn's disease.
    Ferreira F; Lopes S; Macedo G
    BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.